Skip to content

Adverse effects of amikacin on preterm infants kidneys

Adverse kidney effects of standard -daily dosing versus once daily dosing of amikacin among preterm neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015103124804N1
Enrollment
40
Registered
2016-02-05
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial sepsis of newborn. Bacterial sepsis of newborn

Interventions

Intervention 1: Amikacin administration as once daily dose intravenously for 7 days. Intervention 2: Amikacin administration as standard daily dose intravenously for 7 days.
Treatment - Drugs
Amikacin administration as once daily dose intravenously for 7 days
Amikacin administration as standard daily dose intravenously for 7 days

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 7 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria:Appropriate for gestational age preterm infants with early onset sepsis diagnosis Exclusion criteria:neonates with incomplete treatment ; whom their parents do not accept to be included in this trial ; asphyxia; kidney anomalies in ultrasonography

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Urinary NGAL rising. Timepoint: at admission before initialling amikacin and at 7th day after completing treatment. Method of measurement: Using Urinary NGAL kit.

Secondary

MeasureTime frame
Serum cr & BUN rising. Timepoint: at admission and 3th, 5th and 7th day. Method of measurement: by blood sampling.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Bordbar

Iran University of Medical Sciences

bordbar.a@iums.ac.irdrarashbordbar@gmail.comdrabordbar@yahoo.com+98 21 2296 9030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026